Nonbacterial thrombotic endocarditis
Nonbacterial thrombotic endocarditis (NBTE), also known as marantic endocarditis, is a rare form of endocarditis that is not caused by an infection. It is characterized by the formation of sterile thrombi on the heart valves, which can lead to serious complications such as stroke and systemic embolism.
Etiology[edit | edit source]
NBTE is most commonly associated with malignancy, particularly adenocarcinoma and lung cancer. It can also occur in patients with autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Other conditions that can lead to NBTE include sepsis, burns, and trauma.
Pathophysiology[edit | edit source]
In NBTE, the endothelium of the heart valves becomes damaged, leading to the formation of non-infectious thrombi. These thrombi can break off and travel through the bloodstream, causing systemic embolism. The exact mechanism of endothelial damage in NBTE is not fully understood, but it is thought to involve an inflammatory response triggered by malignancy or other underlying conditions.
Clinical Presentation[edit | edit source]
Patients with NBTE often present with symptoms of systemic embolism, such as stroke or myocardial infarction. Other symptoms can include fever, weight loss, and malaise. In many cases, the diagnosis of NBTE is made post-mortem, as the condition can be difficult to detect clinically.
Diagnosis[edit | edit source]
The diagnosis of NBTE is typically made based on the presence of sterile vegetations on echocardiography, in conjunction with clinical symptoms and the absence of a bacterial infection. Other diagnostic tests can include blood cultures and serologic tests for autoimmune diseases.
Treatment[edit | edit source]
The treatment of NBTE primarily involves addressing the underlying condition. This can include chemotherapy for malignancy, or immunosuppressive therapy for autoimmune diseases. Anticoagulation with heparin or warfarin is also typically used to prevent further thrombus formation.
Prognosis[edit | edit source]
The prognosis of NBTE is generally poor, due to the high risk of systemic embolism and the often advanced stage of the underlying condition. However, early detection and treatment can improve outcomes.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD